Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis

Marie Hu, MD, Gaurav Goyal, MBBS, Jason Young, MD, Karen Rech, MD, N. Nora Bennani, MD, Mithun Vinod Shah, MD PhD, Robert Vassallo, MD, Jay H Ryu, MD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 1667.

https://doi.org/10.1182/blood-2019-132104

Published: 2019

Journal Articles

Methotrexate and Cytarabine for Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study

Xinxin Cao, Jian Li, MD, Ai-lin Zhao, Xue-min Gao, Hua-cong Cai, MD, Lu Zhang, MD, Yan Zhang, MD, Jun Feng, MD, Miao Chen, MD, Tie-nan Zhu, MD, Na Niu, Jian Sun, MD, Zhi-yong Liang, MD, Dao-Bin Zhou, Ming-hui Duan, MD

Blood (2019) 134 (Supplement_1): 294.

https://doi.org/10.1182/blood-2019-122220

Published: 2019

Journal Articles

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

Fleur Cohen-Aubart, MD PhD, Ahmed Idbaih, MD PhD, Damien Galanaud, MD PhD, Bruno Law-Ye, MD, Jean-François Emile, MD PhD, Frédéric Charlotte, MD, Jean Donadieu, MD PhD, Zahir Amoura, MD MSc, Julien Haroche

Blood (2019) 134 (Supplement_1): 4272.

https://doi.org/10.1182/blood-2019-130606

Published: 2019

Journal Articles

Clinical Profile and BRAF Status of 30 Japanese Patients with Adult Langerhans Cell Histiocytosis

Miho Ogawa, MD, Masayuki Kobayashi, MD, Koji Jimbo, MD, Toyotaka Kawamata, MD PhD, Kazuaki Yokoyama, MD PhD, Nobuhiro Ohno, MD, Yoichi Imai, MD PhD, Satoshi Takahashi, MD PhD, Arinobu Tojo, MD PhD

Blood (2016) 128 (22): 4883.

https://doi.org/10.1182/blood.V128.22.4883.4883

Published: 2016

Journal Articles

Risk organ + LCH gets the one-two punch?

Kimo C. Stine

Blood (2015) 126 (12): 1399–1400.

https://doi.org/10.1182/blood-2015-08-661496

Published: 2015

Journal Articles

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Harsh Patel, Cary Kraft, Gary J. Schiller, MD FACP

Blood (2014) 124 (21): 5551.

https://doi.org/10.1182/blood.V124.21.5551.5551

Published: 2014

Journal Articles

Clinical Presentation, Diagnosis, Treatment, and Outcome of Patients with Erdheim-Chester Disease: The Mayo Clinic Experience

Mithun Vinod Shah, MD PhD, Timothy G Call, MD, Carl C. Hook, MD, Patrick B. Johnston, MD PhD, Louis Letendre, MD, Joseph P. Colgan, MD, Animesh Pardanani, MBBS, PhD, Bart L. Clarke, MD, Karen L Grogg, MD, Ronald S. Go, MD

Blood (2014) 124 (21): 1405.

https://doi.org/10.1182/blood.V124.21.1405.1405

Published: 2014

Journal Articles

When “rare” is no excuse for progress

Donna Neuberg, Robert J. Arceci

Blood (2013) 121 (25): 4970–4972.

https://doi.org/10.1182/blood-2013-05-498675

Published: 2013

Journal Articles

Impact of Risk Organ Involvement on Outcome in Langerhans Cell Histiocytosis (LCH)

Satyendra Katewa, Anupam Sachdeva, Veronique Dinand, Satya Prakash Yadav, MBBS, DCH, DNB

Blood (2008) 112 (11): 4652.

https://doi.org/10.1182/blood.V112.11.4652.4652

Published: 2008

Journal Articles

A Novel 5′ ATRX Point Mutation with Splicing Consequences in Chronic Myelomonocytic Leukemia with Immune Dysregulation and Acquired Alpha Thalassemia.

Maria E. Nelson, MA, Paul J. Thurmes, MD, James D. Hoyer, MD, David P. Steensma, MD

Blood (2005) 106 (11): 3652.

https://doi.org/10.1182/blood.V106.11.3652.3652

Published: 2005

Journal Articles

Successful treatment of Erdheim-Chester disease, a non–Langerhans-cell histiocytosis, with interferon-α

Fadi Braiteh, Cynthia Boxrud, Bita Esmaeli, Razelle Kurzrock

Blood (2005) 106 (9): 2992–2994.

https://doi.org/10.1182/blood-2005-06-2238

Published: 2005

Journal Articles

AML-M6 Associated with Diabetes Insipidus: Potential Role of Hypophyseal Dysfunction, Monosomy-7 and Impairment of TGF-β1 Signaling in Erythroleukemogenesis.

Andrea Piccin, Maria Marchi, Francesco Rodeghiero, Ugo Rovigatti

Blood (2004) 104 (11): 4422.

https://doi.org/10.1182/blood.V104.11.4422.4422

Published: 2004

Journal Articles

Langerhans Cells Histiocytosis: Description of 6 Cases.

Araceli Rubio, MDPhD, Valle Recasens, MD, Manuela Dobon, MD, Carlos Salvador, MD, Manuel Giralt, MDPhD, Pilar Giraldo, MDPhD

Blood (2004) 104 (11): 3805.

https://doi.org/10.1182/blood.V104.11.3805.3805

Published: 2004

Journal Articles

Recurrent Histiocytosis Evolving to Myelodendritic Leukemia.

Araceli Rubio, MDPhD, Valle Recasens, MD, Carmen Perez-Barrachina, MD, Alberto Orfao, MDPhD, Pilar Giraldo, MDPhD

Blood (2004) 104 (11): 3831.

https://doi.org/10.1182/blood.V104.11.3831.3831

Published: 2004

NARROW

Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis

Methotrexate and Cytarabine for Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

Clinical Profile and BRAF Status of 30 Japanese Patients with Adult Langerhans Cell Histiocytosis

Risk organ + LCH gets the one-two punch?

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Clinical Presentation, Diagnosis, Treatment, and Outcome of Patients with Erdheim-Chester Disease: The Mayo Clinic Experience

When “rare” is no excuse for progress

Impact of Risk Organ Involvement on Outcome in Langerhans Cell Histiocytosis (LCH)

A Novel 5′ ATRX Point Mutation with Splicing Consequences in Chronic Myelomonocytic Leukemia with Immune Dysregulation and Acquired Alpha Thalassemia.

Successful treatment of Erdheim-Chester disease, a non–Langerhans-cell histiocytosis, with interferon-α

AML-M6 Associated with Diabetes Insipidus: Potential Role of Hypophyseal Dysfunction, Monosomy-7 and Impairment of TGF-β1 Signaling in Erythroleukemogenesis.

Langerhans Cells Histiocytosis: Description of 6 Cases.

Recurrent Histiocytosis Evolving to Myelodendritic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only